baber/WOPTO huggingface dataset:
Patent AU-609129-B2 (AU)
Title: Valve actuator for pocket lighter
Inventor: SCHACHTER FRIEDRICH
IPC: F23Q2/16
Filed: 1988-05-11
Granted: 1991-04-26
Abstract: A fuel burning lighter, optionally having an adjustable flame height, comprising a supply of liquified gaseous fuel burner means communicating with the fuel supply, valve means positioned between the fuel supply and the burner means, means to provide first force to retain the valve means in a closed position to prevent gaseous fuel from passing therethrough, and means to provide second force less than the first force biasing the valve means toward an open position. The second force providing means normally provides sufficient force to move the valve means to an open position when the first force is relieved or released from acting upon the valve means.
Patent AU-654352-B2 (AU)
Title: A method for manufacturing a joint pipe
Inventor: SUNDQVIST KRISTIAN
IPC: B29C70/76
Filed: 1992-04-29
Granted: 1994-11-03
Abstract: PCT No. PCT/FI92/00130 Sec. 371 Date Oct. 1, 1993 Sec. 102(e) Date Oct. 1, 1993 PCT Filed Apr. 29, 1992 PCT Pub. No. WO92/19438 PCT Pub. Date Nov. 12, 1992.A method for manufacturing a joint pipe from a spirally wound thermoplastic profile is described in which the pipe end to be furnished with a joint pipe is pushed onto a rotatably driven, slightly conical mandrel, after which a melt profile of thermoplast is extruded and spirally wound in overlapping wraps around the mandrel and the pipe end in a direction extending from a point furthest from the pipe end, followed by cooling of the joint pipe, cutting of its end surface, and removal of the pipe end from the mandrel.
Patent AU-548811-B2 (AU)
Title: Gas as a secondary fuel in diesel engines
Inventor: WOLTERS LEENDERT
IPC: F02D19/08
Filed: 1983-08-11
Granted: 1986-01-02
Abstract: A system for use of gas, like LPG, as secondary fuel in diesel engines is concerned. Normally aspirated and pressure charged engines with exhaust gas driven charging, with End-speed or All-speed governors or with common-rail-fuel injection systems are all included. A signal (24,25) proportional to the momentary effective fuel consumption controls the gas supply (20) to the engine (1). A valve (19) in the gas supply (18) is connected to the control lever (16) of the engine governor (12) to allow gas supply only in a load range above approximately 25% and up to a maximum of approximately 40% of the full load total fuel consumption. In the lower load range uncomplete combustion of the gas thus is avoided, in the higher load range both detonation and overload are avoided and the opacity of the exhaust is improved. The consumption of liquid fuel is reduced and the exhaust gas composition is improved. An adjustable stop (28,29) limits the maximum injectable liquid fuel quantity when the engine is operated in the dual-fuel-mode. The system is designed to be both retrofittable to existing engines and fittable to factory new engines.
Patent AU-578589-B2 (AU)
Title: Concrete strengthening members, particularly prestressing tendons, having improved corrosion resistance and/or bonding characteristics, and methods relating thereto
Inventor: HUNT FREDERICK F
IPC: B05D7/14
Filed: 1983-10-25
Granted: 1988-11-03
Abstract: Concrete strengthening members, particularly prestressing tendons such as strands of steel wire, are provided with a strongly adherent plastic coating which may be substantially impermeable for improved corrosion resistance, and/or which may have embedded therein abrasive or grit-form particles to provide improved bond with the concrete, and particularly to provide controllable bond transfer in prestressing tendons of the pretensioned type. The plastic coating preferably is applied electrostatically in powder form, and fusion bonded by heat. The abrasive can be applied by spraying during a viscous state of the heated resin, and can be varied as to size and spacing density so as to control the surface condition and the bonding effect. Fusion and curing heat may come from preheating of the member before application of the resin powder, which preferably is a heat curable, thermosetting epoxy. Coating thickness and grit application are readily variable to meet particular requirements. Particularly advantageous results are achievable for high strength steel strands for prestressing concrete by pretensioning, facilitating their use where previously considered impractical or impossible.
Patent AU-748240-B2 (AU)
Title: Transporting device for material receptacles
Inventor: MEIER VALENTIN
IPC: B66C1/66
Filed: 1999-04-07
Granted: 2002-05-30
Abstract: With a descending movement of the load arms(6) the load holders(8) are pivoted by protrusions(3) on the sides of the pallet from a first position lying in the vertical direction inside the cross sectional area of the protrusions to a second position located outside this cross sectional area. With an ascending movement of the load arms switching elements located above the load holders on swinging arms(7) are brought into a position in which the load holders are externally guided around the protrusions.
Patent AU-659683-B2 (AU)
Title: Battery with electrochemical tester
Inventor: KUO HAN CHENG
IPC: H01M50/569
Filed: 1992-09-11
Granted: 1995-05-25
Abstract: The present invention relates to an electrochemical cell (50) and a related state of charge indicator (60) comprising an electrochemically generated display (40). The state of charge indicator (60) comprises two electrical contacts (12, 14) and an electrochemically generated display (40) connected therebetween. The display (40) comprises an electrochemical cell (12, 14, 20) that may be permanently connected to a main cell (50) in a parallel configuration via the contacts (12, 14). The condition of the main cell (50) may thus be continuously displayed on the indicator (60).
Patent AU-717346-B2 (AU)
Title: Control method for detonators fitted with an electronic ignition module, encoded firing control unit and ignition module for its implementation.
Inventor: PATHE CLAUDE
IPC: F42C11/06
Filed: 1997-05-21
Granted: 2000-03-23
Abstract: A control method for detonators (1) fitted with an electronic ignition module (15). Each module (15) is associated with specific parameters including at least one identification parameter and one explosion delay time, and includes a firing capacitor and a rudimentary internal clock. The modules (15) are capable of establishing a dialogue with a firing control unit (17) fitted with a reference time basis. The identification parameters are stored in the modules using a programming unit (18); the specific parameters are stored in the firing control unit (17); for each successive module, its internal clock is calibrated using the firing control unit and the associated delay time is sent to the module; the modules are ordered to load the firing capacitors; and a firing order is sent to the modules using the firing control unit, triggering off eventual resetting of the internal clocks as well as a firing sequence.
Patent AU-621605-B2 (AU)
Title: Alkyl-aryl polyglycol ether interface agents for plant protection
Inventor: SZEGO ANDRAS
IPC: A01N25/04
Filed: 1989-04-07
Granted: 1992-03-19
Abstract: The invention relates to ULV plant protecting arthropodicidal formulation comprising alkyl aryl polyglycol ether as further additives in addition to the active ingredient(s) dissolved in the mixture of alphatic hydrocarbons and sunflower oil. The formulation according to the invention has an initial contact angle on the plant surface of > 13 DEG , after 20 minutes of > 6 DEG and it is after 120 minutes still at least 2 DEG .
Patent AU-700490-B2 (AU)
Title: Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement
Inventor: MCGRATH MICHAEL S
IPC: C12Q1/68
Filed: 1995-08-01
Granted: 1999-01-07
Abstract: The presence of clonal macrophages in pre-cancerous and cancerous tissue represents an early stage of the disease in which clonal expansion of macrophages occurs due to HIV integration or other genetic mutation. Clonally expanded macrophages induce proliferation of surrounding tissue leading to cancerous tumor growth. The invention provides methods and kits for diagnosis of HIV- and non-HIV-associated clonal expansion of macrophages in pre-cancerous and cancerous tissue and other cell proliferative diseased tissue. The invention also provides methods for the treatment of cell proliferative diseases induced by clonal macrophage expansion and proliferation of surrounding tissue.
Patent AU-573280-B2 (AU)
Title: Vector interrupt system
Inventor: ZARDIACKAS FREDRICK L
IPC: G06F9/46
Filed: 1984-11-13
Granted: 1988-06-02
Abstract: @ The disclosure relates to a re-vectoring circuit of a microprocessor system wherein pending interrupts are serviced without unnecessary microprocessor state store and restore operations associated with a return-from-interrupt instruction. At the conclusion of an interrupt service routine, an indirect jump instruction is executed throught the same address location of an interrupt vector that the microprocessor indirectly jumped through when the microprocessor was initially interrupted. However, the indirect address is modified, that is, re-vectored to an indirect address within a predetermined address vector depending upon the type of a pending interrupt. The re-vectoring circuit recognizes the indirect jump address and then senses a pending interrupt if there is a pending interrupt. The re-vectoring circuit modifies the indirect address such that a jump occurs to the highest priority pending interrupt service routine. This modification of the indirect address eliminates the store and restore of the microprocessor state in between the servicing of various interrupts.
Patent AU-709240-B2 (AU)
Title: Microcapsules, method of making and their use
Inventor: SCHNEIDER MICHEL
IPC: A61K49/00
Filed: 1995-11-21
Granted: 1999-08-26
Abstract: The invention relates to microcapsules to a microcapsule with a mean size from a fraction of micrometer to 1000 micrometers having a biodegradable membrane encapsulating a gas core. The membrane comprising one or more biodegradable water insoluble lipids or mixtures thereof and optionally mixtures of the lipids with up to 75% by weight of biodegradable polymers encapsulates the core which is filled with air or a gas. Microcapsules disclosed, may be non-coalescent, dry and instantly dispersible, when in suspension in a physiologically acceptable carrier are useful as delivery vehicles for therapeutically active agents and/or as contrast agents for echographic imaging of organs of human or animal body. The microcapsules of the invention are made by a method in which a water-in-oil emulsion is made from an organic solution comprising dissolved a mono-, di-, triglyceride preferably tripalmitin or tristearin and optionally therapeutically active substance and an aqueous solution containing a surfactant, optionally evaporating part of the solvent, adding a redispersing agent and freeze drying the mixture. The freeze dried mixture is then redispersed in an aqueous carrier to separate microcapsules from debris and the semi-spherical or spherical microcapsules are dried.
Patent AU-750409-B2 (AU)
Title: Absorbent interlabial device with substance thereon for maintaining the device in position
Inventor: OSBORN THOMAS WARD III
IPC: A61F13/15
Filed: 1999-04-30
Granted: 2002-07-18
Abstract: An absorbent interlabial device worn by female wearers for catamenial purposes, incontinence protection, or both, is disclosed. The absorbent interlabial device has at least one body-contacting surface which comprises a substance that contacts the wearer's body for assisting the interlabial device in staying in place in the desired position in the interlabial space. The substance can be either adhesive or non-adhesive. In embodiments in which the substance is non-adhesive, it may have no initial tack so that it will not stick to the wrong portions of the wearer's body when the device is placed between the labia. Non-adhesive substances include moisture-activated substances which become viscous and develop a tack when contacted by relatively small amounts of moisture.
Patent AU-619608-B2 (AU)
Title: 3beta,17beta-hydroxy-substituted steroids and related steroidal compounds
Inventor: JOHNSTON J O'NEAL
IPC: A61P43/00
Filed: 1989-10-23
Granted: 1992-01-30
Abstract: The present invention is directed to a group of compounds which are 3 beta ,17 beta -hydroxy steroids, and related steroidal structures. These compounds are aromatase inhibitors, and thus, regulate or inhibit the conversion of androgens to estrogens. These compounds may be utilized to treat conditions potentiated by the presence of estrogens. These compounds exhibit a slower onset of action and a longer half life relative to the 10-(2-alkynyl) steroidal aromatase inhibitors disclosed in U.S. Patent 4,322,416.
Patent AU-633856-B2 (AU)
Title: Fiber optic switch
IPC: G02B6/36
Filed: 1989-10-19
Granted: 1993-02-11
Abstract: A fiber optic switch has a fixed member and a movable member mounted for cantilevered movement with respect thereto. Both of the members are fabricated from borosilicate glass.
Patent AU-716933-B2 (AU)
Title: Thermostable nucleic acid polymerase from (Thermococcus gorgonarius)
Inventor: ANKENBAUER WALTRAUD
IPC: C12Q1/68
Filed: 1997-10-01
Granted: 2000-03-09
Abstract: A purified thermostable enzyme is derived form the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90 % of its activity after incubation for two hours at 95 DEG C in the presence of stabilizing agents and possesses 3'-5' proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR). <IMAGE>
Patent AU-675447-B2 (AU)
Title: Carboxamidomethyl piperidine and analogues
Inventor: SEWARD EILEEN MARY
IPC: A61K31/451
Filed: 1993-07-20
Granted: 1997-02-06
Abstract: PCT No. PCT/GB93/01525 Sec. 371 Date Jan. 24, 1994 Sec. 102(e) Date Jan. 24, 1994 PCT Filed Jul. 20, 1993 PCT Pub. No. WO94/02461 PCT Pub. Date Feb. 3, 1994   <IMAGE>  (I)   <IMAGE>  (a)  Compounds of Formula (I), and salts and prodrugs thereof, wherein n is 1, 2 or 3; X represents O or S; R1 is optionally substituted phenyl; R2 is aryl or heteroaryl; R4 and R5 are independently H, halo, C1-6alkyl, oxo, CH2ORa, CO2Ra or CONRaRb; R8 represents C(COORa)2, C(CONRaRb)2 or C1-6alkyl substituted by C(=NRa)NRbNRcCO2Rd, CONHNRaRb, C(S)NRaRb, CONRaC1-6alkylR12, CONR13C2-6alkynyl, CONR13C2-6alkenyl, COCONRaRb, CONRaC(NRb)NRcRd, CONR13SO2Ra, SO2NR13CORa, CONRaheteroaryl or CORq; Ra, Rb, Rc and Rd are each H, C1-6alkyl, phenyl or trifluoromethyl. R12 represents ORa, CONRaRb or heteroaryl; R13 represents H or C1-6alkyl; and Rq represents a group (a) where Q represents the residue of a non-aromatic azacyclic or azabicyclic ring system; are tachykinin antagonists useful in therapy.
Patent AU-725723-B2 (AU)
Title: Composition containing chitosan
Inventor: KOLBE HANNO
IPC: C12N15/09
Filed: 1997-10-23
Granted: 2000-10-19
Abstract: The invention concerns a chitosan compound having 5 to 300 glucosamine radicals, a substantially pure preparation of chitosan, a composition containing it and the therapeutic use of the latter for transferring a therapeutically active substance into a host cell. The invention also concerns a method for preparing such a compound or such a preparation.
Patent AU-628492-B2 (AU)
Title: Improvements in chemical compounds
Inventor: MURRER BARRY ANTHONY
IPC: A61K31/28
Filed: 1990-03-16
Granted: 1992-09-17
Abstract: Compounds which are cyclic amines having a 12 to 20 membered ring and having from 3 to 5 amino groups in the ring, and their complexes and protected forms are active against retroviruses, and may be used in pharmaceutical compositions to treat infected patients or patients at risk.
Patent AU-636134-B2 (AU)
Title: Process for preparing anthracyclinones
IPC: C07C49/423
Filed: 1990-02-28
Granted: 1993-04-22
Abstract: Process for preparing anthracyclinones of general formula (I): <CHEM> wherein R represents a hydrogen atom or a COOR1 group in which R1 may be a hydrogen atom or an optionally substituted C1-C10 alkyl group, which are intermediates in the preparation of antitumor anthracycline glycosides, are prepared by:   (i)(a) reacting a 4-demethyl-4-sulfonyl-7-deoxy-13-dioxolanyl daunomycinone of formula (V): <CHEM> wherein R min  represents an alkyl group having from 1 to 10 carbon atoms optionally substituted by one or more halogen atoms or an aryl group optionally substituted by halogen, alkyl, alkoxy or nitro, in a reducing environment with a catalytic amount of a compound of formula (VIII):  MLnL min m wherein M represents a transition metal atom, L and L min , which may be the same or different, each represent an anion or a neutral molecule and n and m may vary from 0 to 4, such as to obtain a compound of formula (VII): <CHEM>  wherein R represents hydrogen; or (b) carbonylating a 4-demethyl-4-sulfonyl-7-deoxy-13-dioxolanyl daunomycinone of formula (V) as defined above, with carbon monoxide in the presence of a nucleophile R1OH wherein R1 is as defined above, an organic or inorganic base and as catalyst a compound of formula (VIII) as defined above, such as to obtain a compound of formula (VII) as shown above wherein R represents a COOR1 group; and (ii) introducing an  alpha -hydroxy group at the 7-position and removing the 13-oxo protecting group by acid hydrolysis from the resultant compound of formula (VII). r
Patent AU-637359-B2 (AU)
Title: Cosmetic and pharmaceutical compositions containing hydrophilic derivatives of benzylidenecamphor and new hydrophilic sulphonated derivatives of benzylidenecamphor
IPC: C07C309/24
Filed: 1990-03-30
Granted: 1993-05-27
Abstract: The invention relates to cosmetic and pharmaceutical compositions containing the benzylidenecamphor derivatives of formula: <IMAGE> where R1 and R3 denote H, OH, C1-C8 alkyl or C1-C8 alkoxy, at least one of the radicals R1 and R3 being OH, alkyl or alkoxy, R2 and R4 denoting H or OH, at least one of the radicals R2 and R4 representing OH. The compounds (I) are broad-band sunscreen agents and antioxidants, and are useful in the treatment of skin allergies and inflammations.
Patent AU-740324-B2 (AU)
Title: New triazoles as therapeutic agents for fungal infections
Inventor: DANESHTALAB MOHSEN
IPC: A61K31/496
Filed: 1998-01-15
Granted: 2001-11-01
Abstract: A compound of formula (I), or an optical isomer or pharmaceutically acceptable salt thereof, is disclosed as well as a pharmaceutical composition and a method of treating or preventing a fungal infection using the compound.
Patent AU-715935-B2 (AU)
Title: A method of establishing the presence of specific substances in milk as well as an implement for applying same
Inventor: BERG KAREL VAN DEN
IPC: A01J7/00
Filed: 1998-01-08
Granted: 2000-02-10
Abstract: A method of establishing the presence of specific substances, such as contaminations, in the milk yielded from individual animals and obtained at consecutive milking runs, comprises the following steps: with the aid of a color sensor measuring system (9) the intensity of frequencies in a number of defined frequency bands, in particular the intensity of a number of defined colours in the milk, is established; the intensity values obtained are subsequently stored in a data file that is present for a relevant animal in a computer (13), whereafter these intensity values are compared both mutually and with corresponding intensity values recorded during one or more previous milking runs and the results of this comparison process are indicated.
Patent AU-589851-B2 (AU)
Title: Transaction system with off-line risk assessment
Inventor: BOSTON VINCENT
IPC: G07F7/08
Filed: 1986-04-23
Granted: 1989-10-19
Abstract: In a transaction system the issuer (20) of transaction cards (30) can regulate the type of authorization requests transmitted from the point of transaction. Each transaction card is provided with risk assessment date (32) associated with the cardholder. Each remote transaction terminal (40) can read the information (32) placed on the transaction card (30). In operation, the risk assessment data (32) is compared with the transaction amount by the terminal (40). If the transaction is approved, the terminal (40) will issue an automatic, off-line authorization. If the transaction does not fall within the approval range, the terminal (40) will function to transmit the transaction information to the issuer (20) for evaluation. The issuer (20) can then determine whether to authorize the transaction based on its own date base (22).
Patent AU-718718-B2 (AU)
Title: Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
Inventor: NATHANS JEREMY
IPC: A61K31/70
Filed: 1996-05-10
Granted: 2000-04-20
Abstract: A novel protein, fibroblast growth factor homologous factor-1 (FHF-1), the polynucleotide sequence encoding FHF-1, and the deduced amino acid sequence are disclosed. Also disclosed are diagnostic and therapeutic methods of using the FHF-1 polypeptide and polynucleotide sequences and antibodies which specifically bind to FHF-1.
Patent AU-739284-B2 (AU)
Title: Plant containing composition
Inventor: TAKEDA MINORU
IPC: A01G31/00
Filed: 1998-03-13
Granted: 2001-10-11
Abstract: Disclosed is a composition comprising a plant capable of growing in the presence of at least water and light, a nonionic water-absorptive polymer, and water, and a method of use of the composition as well as a method of fabricating a revegetation material.
Patent AU-754798-B2 (AU)
Title: Corrosion inhibitors and synergistic inhibitor combinations for the protection of light metals in heat-transfer fluids and engine coolants
Inventor: MAES JEAN-PIERRE
IPC: C23F11/08
Filed: 1999-10-11
Granted: 2002-11-28
Abstract: Corrosion protection of magnesium and aluminium alloys in engine coolants and heat-exchange fluids is achieved by the use of a select group of aliphatic and aromatic carboxylate acids or the alkaline metal, ammonium or amine salts thereof. The addition of a fluoride and/or a fluorocarboxylic acid or salt thereof have been found to significantly improve the high temperature magnesium corrosion protection properties.
Patent AU-731044-B2 (AU)
Title: Compositions and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof
Inventor: FILBIN MARIE T
IPC: C07K14/705
Filed: 1996-06-27
Granted: 2001-03-22
Abstract: This invention relates to the novel identification of myelin-associated glycoprotein ("MAG") as a potent inhibitor of neural regeneration. More particularly, this invention relates to compositions and methods useful for reversing inhibition of neural regeneration in the central and peripheral nervous system. Assays to monitor the effects of MAG on neural regeneration and to identify agents which will block or promote the inhibitory effects of MAG on neural outgrowth are provided. Screening methods for identifying such agents are also provided. This invention also relates to compositions and methods using agents that can reverse the inhibitory effects of MAG on neural regeneration. Methods for regulating and for promoting neural growth or regeneration in the nervous system, methods for treating injuries or damage to nervous tissue or neurons, and methods for treating neural degeneration associated with disorders or diseases, comprising the step of administering at least one of the compositions according to this invention are provided.
Patent AU-638512-B2 (AU)
Title: Protection of lead-containing anodes during chromium electroplating
IPC: C25D3/04
Filed: 1990-11-06
Granted: 1993-07-01
Abstract: The present invention provides a process for electroplating chromium using lead anodes while achieving the advantages of using methanesulfonic acid without suffering the excessive anode-corrosion characteristics associated with that acid. Accordingly, chromium is electrodeposited from a bath containing chromic acid, sulfate and an alkylpolysulfonic acid containing from one to about three carbon atoms. The invention also provides a plating process for chromium electrodeposition, a plating bath for use in the inventive process, and a replenishment composition for existing plating baths.